Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Adh Migr ; 6(1): 49-58, 2012.
Article in English | MEDLINE | ID: mdl-22647940

ABSTRACT

In this article, I discuss the hallmarks of hypoxia in vitro and in vivo and review work showing that many types of stem cell proliferate more robustly in lowered oxygen. I then discuss recent studies showing that alterations in the levels and the types of cell and substrate adhesion molecules are a notable response to reduced O(2) levels in both cultured primary neural stem cells and brain tissues in response to hypoxia in vivo. The ability of O(2) levels to regulate adhesion molecule expression is linked to the Wnt signaling pathway, which can control and be controlled by adhesion events. The ability of O(2) levels to influence cell adhesion also has far-reaching implications for development, ischemic trauma and neural regeneration, as well as for cancer and other diseases. Finally I discuss the possibility that the fluctuations in O(2) levels known to have occurred over evolutionary time could, by influencing adhesion systems, have contributed to early symbiotic events in unicellular organisms and to the emergence of multicellularity. It is not my intention to be exhaustive in these domains, which are far from my own field of study. Rather this article is meant to provoke and stimulate thinking about molecular evolution involving O(2) sensing and signaling during eras of geologic and atmospheric change that might inform modern studies on development and disease.


Subject(s)
Evolution, Molecular , Morphogenesis , Nervous System/metabolism , Oxygen/metabolism , Animals , Atmosphere , Brain Ischemia , Cell Adhesion , Cell Proliferation , Hypoxia, Brain/metabolism , Hypoxia, Brain/pathology , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Nervous System/cytology , Neural Cell Adhesion Molecules/metabolism , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neurogenesis , Symbiosis , Wnt Signaling Pathway
2.
J Biol Chem ; 286(20): 17649-57, 2011 May 20.
Article in English | MEDLINE | ID: mdl-21460212

ABSTRACT

Recent studies have shown that various neural and embryonic stem cells cultured in 1-8% oxygen (O(2)), levels lower than those typically used in cell culture (20.9%), displayed increased rates of proliferation; however, the molecular mechanisms underlying these changes are largely undefined. In this study, using rigorously controlled O(2) levels, we found that neural stem cells (NSCs) from embryonic day 15 rat cortex increased their rate of proliferation and migration in 1% O(2) relative to 20% O(2) without changes in viability. We sought to identify molecular changes in NSCs grown in 1% O(2) that might account for these increases. In 1% O(2), levels of the hypoxia-inducible transcription factor HIF-1α were transiently increased. Reduced adherence of NSCs in 1% O(2) to basement membrane-coated plates was observed, and quantitative RT-PCR analysis confirmed that the levels of mRNA for an assortment of cell adhesion and extracellular matrix molecules were altered. Most notable was a 5-fold increase in matrix metalloproteinase (MMP)-9 mRNA. Specific inhibition of MMP-9 activity, verified using a fluorescent substrate assay, prevented the increase in proliferation and migration in 1% O(2). The canonical Wnt pathway was recently shown to be activated in stem cells in low O(2) via HIF-1α. Inhibition of Wnt signaling by DKK-1 also prevented the increase in proliferation, migration, and MMP-9 expression. Thus, MMP-9 is a key molecular effector, downstream of HIF-1α and Wnt activation, responsible for increased rates of NSC proliferation and migration in 1% O(2).


Subject(s)
Cell Movement/physiology , Cell Proliferation , Embryonic Stem Cells/enzymology , Matrix Metalloproteinase 9/biosynthesis , Neural Stem Cells/enzymology , Oxygen/metabolism , Signal Transduction/physiology , Wnt Proteins/metabolism , Animals , Cell Adhesion/physiology , Cell Hypoxia/physiology , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Cerebral Cortex/enzymology , Embryo, Mammalian/cytology , Embryo, Mammalian/enzymology , Embryonic Stem Cells/cytology , Gene Expression Regulation, Enzymologic/physiology , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Neural Stem Cells/cytology , Rats , Rats, Wistar
3.
Mol Cell Neurosci ; 36(4): 472-83, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17904380

ABSTRACT

Axonal transport of mitochondria is critical for proper neuronal function. However, little is known about the extracellular signals that regulate this process. In the present study, we show that the neuromodulator serotonin (5-HT) greatly enhances mitochondrial movement in the axons of rat hippocampal neurons in vitro. Administration of a 5-HT1A receptor antagonist inhibited mitochondrial movement, whereas addition of fluoxetine, a selective serotonin reuptake inhibitor, promoted mitochondrial movement. 5-HT receptors are known to activate the Akt/Protein kinase B pathway. Consistent with this, directional mitochondrial movement was almost completely blocked by a specific Akt inhibitor. Moreover, an inhibitor of glycogen synthase kinase-3beta (GSK3beta), a kinase whose activity is blocked by Akt-mediated phosphorylation, promoted mitochondrial movement. These findings show that 5-HT1A receptor activation stimulates mitochondrial movement in hippocampal neurons by inhibiting GSK3beta activity via Akt. Our findings suggest that 5-HT may mediate the redistribution of energy sources within responsive neurons, a possibility that has significant implications for understanding the global biological effects of this important neuromodulator.


Subject(s)
Axonal Transport/physiology , Axons/metabolism , Hippocampus/metabolism , Mitochondria/metabolism , Serotonin/metabolism , Signal Transduction/physiology , Animals , Axonal Transport/drug effects , Axons/drug effects , Axons/ultrastructure , Cell Line , Cells, Cultured , Energy Metabolism/drug effects , Energy Metabolism/physiology , Enzyme Inhibitors/pharmacology , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Hippocampus/cytology , Humans , Mitochondria/drug effects , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/metabolism , Rats , Receptor, Serotonin, 5-HT1A/metabolism , Serotonin/pharmacology , Serotonin 5-HT1 Receptor Antagonists , Serotonin Antagonists/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Signal Transduction/drug effects
4.
Mol Cell Neurosci ; 33(4): 345-57, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17000118

ABSTRACT

Reactive oxygen species (ROS) are important regulators of intracellular signaling. We examined the expression of ROS during rat brain development and explored their role in differentiation using cortical cultures. High levels of ROS were found in newborn neurons. Neurons produced ROS, not connected with cell death, throughout embryogenesis and postnatal stages. By P20, ROS-producing cells were found only in neurogenic regions. Cells with low levels of ROS, isolated from E15 brains by FACS, differentiated into neurons, oligodendrocytes, and astrocytes in clonal cultures. Neurons produced high ROS early in culture and later differentiated into two types: large pyramidal-like neurons that fired no or only a single action potential and smaller neurons that expressed nuclear calretinin and fired repeated action potentials. Antioxidant treatment did not alter neuron number but increased the ratio of small to large neurons. These findings suggest that modulation of ROS levels influences multiple aspects of neuronal differentiation.


Subject(s)
Cell Differentiation/physiology , Cerebral Cortex/cytology , Gene Expression Regulation, Developmental/physiology , Neurons/physiology , Reactive Oxygen Species/metabolism , Analysis of Variance , Animals , Animals, Newborn , Cells, Cultured , Electric Stimulation/methods , Embryo, Mammalian , Flow Cytometry/methods , Immunohistochemistry/methods , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Microscopy, Confocal/methods , Neurons/classification , Neurons/drug effects , Patch-Clamp Techniques/methods , Rats
5.
Brain Res ; 1040(1-2): 137-50, 2005 Apr 08.
Article in English | MEDLINE | ID: mdl-15804435

ABSTRACT

A population of embryonic rat cortical cells cultured in the presence of FGF2 and having neuronal morphology expressed higher levels of reactive oxygen species (ROS) than did progenitor cells, astrocytes, and several cell lines of neuronal and non-neuronal origin. ROS were assessed using 5-(and-6)-chlormethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCF-DA), and high levels persisted in the presence of antioxidants or lowered levels of ambient oxygen. Greater than 95% of high ROS-producing cells, isolated by fluorescence-activated cell sorting, expressed the neuronal marker beta III tubulin. These cells did not incorporate BrdU or express nestin, unlike low ROS-producing cells, 99% of which exhibited both of these characteristics. Upon growth factor removal, low ROS-expressing cells differentiated into neurons and astrocytes and these neurons expressed high levels of ROS, indicating that ROS accumulation accompanies the differentiation of progenitors into neurons. ROS levels were decreased by added superoxide dismutase and catalase, suggesting that both superoxide and hydrogen peroxide contribute to the ROS signal. High ROS-expressing cells also contained higher levels of several mitochondrial respiratory chain components. Although ROS have been associated with conditions that lead to cell death, our results and recent studies on the role of ROS as regulators of signal pathways are consistent with the possibility that ROS play a role in the development of the neuronal phenotype. Moreover, the differential production of ROS provides a useful method to isolate from mixed populations cells that are highly enriched for either progenitor cells or neurons.


Subject(s)
Animals, Newborn/physiology , Cell Differentiation/physiology , Mitochondrial Proteins/biosynthesis , Neurons/metabolism , Reactive Oxygen Species/metabolism , Stem Cells/metabolism , Animals , Cells, Cultured , Female , Mitochondrial Proteins/analysis , Neurons/chemistry , Neurons/cytology , Pregnancy , Rats , Rats, Wistar , Reactive Oxygen Species/analysis , Stem Cells/chemistry , Stem Cells/cytology
7.
Proc Natl Acad Sci U S A ; 99(3): 1621-6, 2002 Feb 05.
Article in English | MEDLINE | ID: mdl-11818538

ABSTRACT

We previously demonstrated that the neural cell adhesion molecule (N-CAM) inhibited the proliferation of cultured rat hippocampal progenitor cells and increased the number of neurons generated. We demonstrate here that the continued presence of fibroblast growth factor 2 along with N-CAM or brain-derived neurotrophic factor over 12 days of culture greatly increased the number of both progenitors and neurons. These progenitor-derived neurons expressed neurotransmitters, neurotransmitter receptors, and synaptic proteins in vitro consistent with those expressed in the mature hippocampus. Progenitor cells cultured on microelectrode plates formed elaborate neural networks that exhibited spontaneously generated action potentials after 21 days. This activity was observed only in cultures grown in the presence of fibroblast growth factor 2 and either N-CAM or brain-derived neurotrophic factor. Analysis of neuronal activity after various pharmacological treatments indicated that the networks formed functional GABAergic and glutamatergic synapses. We conclude that mitogenic growth factors can synergize with N-CAM or neurotrophins to generate spontaneously active neural networks from neural progenitors.


Subject(s)
Hippocampus/physiology , Nerve Net/physiology , Stem Cells/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Biomarkers/analysis , Brain-Derived Neurotrophic Factor/analysis , Brain-Derived Neurotrophic Factor/pharmacology , Cells, Cultured , Embryo, Mammalian , Fibroblast Growth Factor 2/analysis , Fibroblast Growth Factor 2/pharmacology , Microelectrodes , Neural Cell Adhesion Molecules/analysis , Neural Cell Adhesion Molecules/pharmacology , Rats , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...